ALGOMETRX INC
Washington, DC · Founded 2015 · CIK 0001704274 · Medtech · Private
Objective pain measurement device and algorithm for real-time monitoring of analgesic efficacy
algometrx.com →- Grants
- $1.2M
- 4 awards
- Sector median: 1
- Raised
- $1.9M
- 3 Form D · Dec 2021
- 58 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Objective Pain Biometric Device and Method | $224,173 | |
| Private capital raised | Form D · SEC | $875,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Use of a novel physiologic measure for the assessment and monitoring of vincristine induced peripheral neuropathy (VIPN) in children and adolescents. | $396,711 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a novel technology for the determination of a physiologic phenotype in patients with Systemic Lupus Erythematosus | $272,392 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a novel technology for the determination of a physiologic phenotype in patients with Systemic Lupus Erythematosus | $272,392 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1141 | RODO MEDICAL, INC. | — | $7.7M |
| 1142 | BioAesthetics Corporation | — | $5.0M |
| 1143 | Nirvana Sciences, Inc. | — | $1.7M |
| 1144 | ALGOMETRX INC | — | $1.9M |
| 1145 | SS Innovations International, Inc. | — | $22M |
| 1146 | VeinSound, Inc. | — | $100K |
| 1147 | MEGANANO DIAGNOSTICS INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Julia FinkelDirector
- David GrossDirector · Executive Officer
- David HellerDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.